Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Evolent Health, Inc.EVH · Entity 5492 | Director | June 06, 2024 | June 10, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Evolent Health, Inc.
Report date June 06, 2024 · Filed June 10, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 48,001 |
Reported balance
After 2024-06-06 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-06-06 · Grant · Acquired 7,709 · Balance 48,001 F1: Represents restricted stock units granted to Dr. Duffy pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2: Securities vest on the earlier of June 6, 2025, and the date of the Company's 2025 annual meeting, subject to the reporting person's continued service on the vesting date. F3: Since the date of the reporting person's last ownership report, Dr. Duffy transferred 9,643 shares of Evolent Health, Inc. Class A Common Stock pursuant to a domestic relations order. Dr. Duffy no longer reports as beneficially owned any securities owned by her ex-spouse. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units granted to Dr. Duffy pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2: Securities vest on the earlier of June 6, 2025, and the date of the Company's 2025 annual meeting, subject to the reporting person's continued service on the vesting date.
F3: Since the date of the reporting person's last ownership report, Dr. Duffy transferred 9,643 shares of Evolent Health, Inc. Class A Common Stock pursuant to a domestic relations order. Dr. Duffy no longer reports as beneficially owned any securities owned by her ex-spouse.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
VOCERA COMMUNICATIONS, INC.
Report date February 18, 2022 · Filed February 23, 2022
Section 16 reporting ended · disclosed 2022-02-23. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2022-02-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-02-18 · Grant · Acquired 54,266 · Balance 117,723 F1: Represents the number of shares that vested under (a) a performance stock unit award granted on June 1, 2020 and (b) a performance stock unit award granted on July 1, 2021. Row 2 · 2022-02-23 · Disposition to issuer · Disposed 117,723 · Balance 0 F2: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 6, 2022, by and among the Issuer, Stryker Corporation ("Stryker") and Voice Merger Sub Corp. ("Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Stryker, effective as of February 23, 2022 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the common stock was exchanged into the right to receive $79.25 in cash, without interest and less any applicable withholding taxes, at the Effective Time. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares that vested under (a) a performance stock unit award granted on June 1, 2020 and (b) a performance stock unit award granted on July 1, 2021.
F2: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 6, 2022, by and among the Issuer, Stryker Corporation ("Stryker") and Voice Merger Sub Corp. ("Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Stryker, effective as of February 23, 2022 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the common stock was exchanged into the right to receive $79.25 in cash, without interest and less any applicable withholding taxes, at the Effective Time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 06, 2024 Filed Jun 10, 2024 19:34 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 7,709 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000074 · wk-form4_1718062477.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,001 F1 · security: Represents restricted stock units granted to Dr. Duffy pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 6, 2025, and the date of the Company's 2025 annual meeting, subject to the reporting person's continued service on the vesting date. F3 · balance_after: Since the date of the reporting person's last ownership report, Dr. Duffy transferred 9,643 shares of Evolent Health, Inc. Class A Common Stock pursuant to a domestic relations order. Dr. Duffy no longer reports as beneficially owned any securities owned by her ex-spouse. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 16:24 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 5,564 | $30.97 | $172,317.08 |
DisclosureSEC source: 0001628908-23-000101 · wf-form4_168686065872798.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,935 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.77 to $31.24, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 17:23 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 5,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-23-000091 · wf-form4_168660498858162.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,499 F1 · security: Represents restricted stock units granted to Dr. Duffy pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 8, 2024 and the date of the Company's 2024 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 18:09 UTC | Evolent Health, Inc. EVH · Entity 5492 | SaleClass A Common Stock | 7,500 | $33.13 | $248,475.00 |
DisclosureSEC source: 0001628908-22-000120 · wf-form4_166086052563047.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,450 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.080 to $33.165, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 18:07 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 5,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-22-000073 · wf-form4_165515805560834.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,950 F1 · security: Represents restricted stock units granted to Dr. Duffy pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 9, 2023 and the date of the company's 2023 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| February 23, 2022 Filed Feb 23, 2022 17:48 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | Disposition to issuerCommon Stock | 117,723 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-012330 · doc4.xml · nonDerivative · entry 2 DUFFY MARY BRIDGET · CIK 0001570881 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 6, 2022, by and among the Issuer, Stryker Corporation ("Stryker") and Voice Merger Sub Corp. ("Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Stryker, effective as of February 23, 2022 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the common stock was exchanged into the right to receive $79.25 in cash, without interest and less any applicable withholding taxes, at the Effective Time. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 17:48 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | GrantCommon Stock | 54,266 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012330 · doc4.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,723 F1 · shares: Represents the number of shares that vested under (a) a performance stock unit award granted on June 1, 2020 and (b) a performance stock unit award granted on July 1, 2021. Read SEC document |
| December 10, 2021 Filed Dec 10, 2021 18:59 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | SaleCommon Stock | 734 | $58.36 | $42,836.24 |
DisclosureSEC source: 0001209191-21-069126 · doc4.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,457 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 19:08 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | SaleCommon Stock | 734 | $57.96 | $42,542.64 |
DisclosureSEC source: 0001209191-21-064874 · doc4.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,191 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| October 12, 2021 Filed Oct 13, 2021 19:28 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | SaleCommon Stock | 723 | $46.32 | $33,489.36 |
DisclosureSEC source: 0001209191-21-060420 · doc4.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,925 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 13, 2021 Filed Sep 14, 2021 20:01 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | SaleCommon Stock | 731 | $47.68 | $34,854.08 |
DisclosureSEC source: 0001209191-21-056075 · doc4.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,648 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 12, 2021 Filed Aug 13, 2021 19:03 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | SaleCommon Stock | 730 | $44.49 | $32,477.70 |
DisclosureSEC source: 0001209191-21-051492 · doc4.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,379 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 13, 2021 Filed Jul 14, 2021 18:47 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | SaleCommon Stock | 748 | $41.17 | $30,795.16 |
DisclosureSEC source: 0001209191-21-046699 · doc4.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,109 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 17:49 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | GrantCommon Stock | 16,058 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-045114 · doc4.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,857 F1 · shares: Represents a restricted stock unit award that vests in three substantially equal installments on each of July 1, 2022, June 1, 2023 and June 1, 2024. Read SEC document |
| June 24, 2021 Filed Jun 25, 2021 19:23 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | Tax withholdingCommon Stock | 2,084 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-043415 · doc4.xml · nonDerivative · entry 2 DUFFY MARY BRIDGET · CIK 0001570881 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,799 F2 · kind: Exempt transaction pursuant to Section 16b-3(e) - Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and withheld by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of shares of performance stock units. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes. F2 · price: Exempt transaction pursuant to Section 16b-3(e) - Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and withheld by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of shares of performance stock units. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes. Read SEC document |
| June 23, 2021 Filed Jun 25, 2021 19:23 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | GrantCommon Stock | 4,430 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-043415 · doc4.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,883 F1 · shares: Represents the number of shares that vested under a performance stock unit granted on June 1, 2020. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 19:24 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | SaleCommon Stock | 716 | $37.24 | $26,663.84 |
DisclosureSEC source: 0001209191-21-040748 · doc4.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,453 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 17:31 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 7,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-21-000075 · wf-form4_162370627911780.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,386 F1 · security: Represents restricted stock units granted to Ms. Duffy pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 10, 2022 and the date of the company's 2022 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 20:19 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | Tax withholdingCommon Stock | 14,305 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-037989 · doc4.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,169 F1 · kind: Exempt transaction pursuant to Section 16b-3(e) - Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and withheld by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of shares of restricted stock units. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes. F1 · price: Exempt transaction pursuant to Section 16b-3(e) - Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and withheld by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of shares of restricted stock units. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 20:02 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $24.15 | $0.00 |
DisclosureSEC source: 0001209191-21-004980 · doc4.xml · derivative · entry 4 DUFFY MARY BRIDGET · CIK 0001570881 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2022-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 20:02 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | SaleCommon Stock | 3,700 | $45.03 | $166,599.16 |
DisclosureSEC source: 0001209191-21-004980 · doc4.xml · nonDerivative · entry 3 DUFFY MARY BRIDGET · CIK 0001570881 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,474 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $45.01 to $45.12 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 20:02 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | SaleCommon Stock | 3,800 | $44.34 | $168,480.60 |
DisclosureSEC source: 0001209191-21-004980 · doc4.xml · nonDerivative · entry 2 DUFFY MARY BRIDGET · CIK 0001570881 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,174 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $43.85 to $44.78 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 20:02 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | Exercise / conversionCommon Stock | 7,500 | $24.15 | $181,125.00 |
DisclosureSEC source: 0001209191-21-004980 · doc4.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,974 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2020 Filed Jun 17, 2020 19:44 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | SaleCommon Stock | 3,766 | $20.10 | $75,697.73 |
DisclosureSEC source: 0001209191-20-037435 · doc4.xml · nonDerivative · entry 3 DUFFY MARY BRIDGET · CIK 0001570881 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,474 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $20.00 to $20.45 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 19:44 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | SaleCommon Stock | 4,868 | $20.73 | $100,936.03 |
DisclosureSEC source: 0001209191-20-037435 · doc4.xml · nonDerivative · entry 2 DUFFY MARY BRIDGET · CIK 0001570881 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,240 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $20.665 to $20.82 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 19:44 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | SaleCommon Stock | 3,949 | $20.00 | $78,980.00 |
DisclosureSEC source: 0001209191-20-037435 · doc4.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,108 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 09, 2020 Filed Jun 11, 2020 17:33 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 18,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-20-000079 · wf-form4_159191120090351.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,601 F1 · security: Represents restricted stock units granted to Dr. Duffy pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 9, 2021 and the date of the company's 2021 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:29 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | Tax withholdingCommon Stock | 12,375 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-034282 · doc4.xml · nonDerivative · entry 2 DUFFY MARY BRIDGET · CIK 0001570881 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,057 F2 · kind: Exempt transaction pursuant to Section 16b-3(e) - Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and withheld by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of shares of restricted stock units. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes. F2 · price: Exempt transaction pursuant to Section 16b-3(e) - Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and withheld by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of shares of restricted stock units. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:29 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | GrantCommon Stock | 39,872 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-034282 · doc4.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,432 F1 · shares: Represents a restricted stock unit award that vests in three equal annual installments commencing on June 1, 2021. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 07:54 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 14,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-19-000040 · primary_doc.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,299 F1 · security: Represents restricted stock units granted to Dr. Duffy pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 11, 2020 and the date of the company's 2020 annual meeting, subject to the reporting person's continued service on the vesting date. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| June 10, 2019 Filed Jun 11, 2019 18:59 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | SaleCommon Stock | 16,225 | $30.45 | $494,059.36 |
DisclosureSEC source: 0001567619-19-013236 · doc1.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,560 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $29.91 to $30.785 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 21:31 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | Tax withholdingCommon Stock | 15,957 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-19-012786 · doc1.xml · nonDerivative · entry 2 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,785 F2 · kind: Exempt transaction pursuant to Section 16b-3(e) - Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and withheld by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of shares of restricted stock units. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes. F2 · price: Exempt transaction pursuant to Section 16b-3(e) - Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and withheld by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of shares of restricted stock units. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:31 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | GrantCommon Stock | 22,414 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-012786 · doc1.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,742 F1 · shares: Represents a restricted stock unit award that vests in three equal annual installments commencing on June 1, 2020. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 20:05 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | Exercise / conversionStock Option (Right to Buy) · Derivative | 31,545 | $0.00 Strike: $14.76 | $0.00 |
DisclosureSEC source: 0001567619-19-006527 · doc1.xml · derivative · entry 3 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,545 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option vests as to 1/48th of the total number of shares in equal monthly installments commencing on June 30, 2013. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 20:05 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | SaleCommon Stock | 31,545 | $32.21 | $1,016,089.69 |
DisclosureSEC source: 0001567619-19-006527 · doc1.xml · nonDerivative · entry 2 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,328 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $31.97 to $32.55 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 20:05 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | Exercise / conversionCommon Stock | 31,545 | $14.76 | $465,604.20 |
DisclosureSEC source: 0001567619-19-006527 · doc1.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 20, 2018 Filed Jun 22, 2018 19:18 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $12.92 | $0.00 |
DisclosureSEC source: 0001140361-18-029663 · doc1.xml · derivative · entry 6 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2024-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The stock option vests as to 1/48th of the total number of shares in equal monthly installments commencing on July 1, 2014. Read SEC document |
| June 20, 2018 Filed Jun 22, 2018 19:18 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | SaleCommon Stock | 15,000 | $30.02 | $450,357.00 |
DisclosureSEC source: 0001140361-18-029663 · doc1.xml · nonDerivative · entry 4 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,328 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $30.00 to $30.30 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 20, 2018 Filed Jun 22, 2018 19:18 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | Exercise / conversionCommon Stock | 15,000 | $12.92 | $193,800.00 |
DisclosureSEC source: 0001140361-18-029663 · doc1.xml · nonDerivative · entry 3 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,328 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 19, 2018 Filed Jun 22, 2018 19:18 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,427 | $0.00 Strike: $12.92 | $0.00 |
DisclosureSEC source: 0001140361-18-029663 · doc1.xml · derivative · entry 5 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 1,427 shares Expires 2024-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The stock option vests as to 1/48th of the total number of shares in equal monthly installments commencing on July 1, 2014. Read SEC document |
| June 19, 2018 Filed Jun 22, 2018 19:18 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | SaleCommon Stock | 1,427 | $30.00 | $42,810.00 |
DisclosureSEC source: 0001140361-18-029663 · doc1.xml · nonDerivative · entry 2 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,328 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 19, 2018 Filed Jun 22, 2018 19:18 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | Exercise / conversionCommon Stock | 1,427 | $12.92 | $18,436.84 |
DisclosureSEC source: 0001140361-18-029663 · doc1.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 18:42 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | SaleCommon Stock | 19,474 | $29.06 | $565,968.97 |
DisclosureSEC source: 0001140361-18-029198 · doc1.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,328 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $28.92 to $29.24 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 16:38 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 5,459 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-18-000043 · primary_doc.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,143 F1 · security: Represents restricted stock units granted to Dr. Duffy pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 13, 2019 and the date of the company's 2019 annual meeting, subject to the reporting person's continued service on the vesting date. F3 · balance_after: Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:53 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | GrantCommon Stock | 28,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-027500 · doc1.xml · nonDerivative · entry 2 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,802 F3 · shares: Represents a restricted stock unit award that vests in three equal annual installments commencing on June 1, 2019. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:53 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | Tax withholdingCommon Stock | 17,898 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-027500 · doc1.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,834 F1 · kind: Exempt transaction pursuant to Section 16b-3(e) - Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and withheld by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of shares of restricted stock units. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes. F1 · price: Exempt transaction pursuant to Section 16b-3(e) - Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and withheld by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of shares of restricted stock units. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes. F2 · balance_after: Includes the amended balance which, as a result of an administrative error, adds 283 shares that were indirectly held by the Reporting Person but were reported as directly sold on a Form 4 filed on March 5, 2018 resulting in the Reporting Person owning 283 shares less in the Reporting Person's direct holdings. This Form 4 corrects the error to reflect that 283 shares were sold in the Reporting Person's indirect account resulting in a zero balance. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 16:52 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | SaleCommon Stock | 283 | $26.58 | $7,522.68 |
DisclosureSEC source: 0001140361-18-012004 · doc1.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,449 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $26.48 to $26.76 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 17:44 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 6,684 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-17-000045 · primary_doc.xml · nonDerivative · entry 1 DUFFY MARY BRIDGET · CIK 0001570881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,684 F1 · security: Represents restricted stock units granted to Dr. Duffy pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on October 2, 2018. Read SEC document |
| July 05, 2017 Filed Jul 6, 2017 19:20 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | SaleCommon Stock | 3,137 | $25.92 | $81,312.92 |
DisclosureSEC source: 0001140361-17-027389 · doc1.xml · nonDerivative · entry 3 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,732 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $25.91 to $25.97 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| July 05, 2017 Filed Jul 6, 2017 19:20 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | SaleCommon Stock | 20,870 | $25.39 | $529,968.61 |
DisclosureSEC source: 0001140361-17-027389 · doc1.xml · nonDerivative · entry 2 DUFFY MARY BRIDGET · CIK 0001570881 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,869 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $24.91 to $25.90 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.